Rowan McEvoy, B.S.

Policy Lead
Acumen, LLC
Burlingame, United States

Disclosure information not submitted.

Presentation(s):

• Added Benefit and Waning Effectiveness of a Third-Dose mRNA COVID-19 Vaccine in Community-Dwelling Medicare Beneficiaries Aged ≥65 Years in Omicron Period

  Tuesday, August 27, 2024
  8:15 AM – 8:30 AM CEST